Researchers identify a novel host-directed therapeutic approach to COVID-19

By | June 8, 2021
Researchers in the UK have demonstrated the potential of modulating the expression of angiotensin-converting enzyme 2 (ACE2) as a novel host-directed therapeutic approach to protecting against coronavirus disease 2019 (COVID-19).